Skip to main content

Want a detailed portfolio tracker?

Clearside Biomedical, Inc. Common Stock (CLSD) Profit Margin (2016 - 2025)

Clearside Biomedical, Inc. Common Stock (CLSD) profit margin from Jun 30, 2016 to Sep 30, 2025. The current Clearside Biomedical, Inc. Common Stock (CLSD) profit margin is -2985.00%. You can export chart.

Annual Profit Margin

Quarterly Profit Margin

Annual Profit Margin change of Clearside Biomedical, Inc. Common Stock (CLSD)

YearProfit MarginChange
2024-2069.28%
+424.33%
2023-394.65%
-84.07%
2022-2477.44%
-192949.43%
20211.28%
-100.56%
2020-230.80%
-83.72%
2019-1417.97%
-99.49%
2018-276066.67%
+1538.52%
2017-16848.57%
+238.53%
2016-4976.92%
N/A

Comparison Clearside Biomedical, Inc. Common Stock (CLSD) profit margin with competitors

Clearside Biomedical, Inc. Common Stock (CLSD) profit margin is -2985.00%.

TickerNameProfit MarginUpside
OMEROmeros Corporation871.00%-129.18%
PRTCPureTech Health plc American Depositary Shares793.00%-126.57%
ABEOAbeona Therapeutics Inc454.90%-115.24%
CHRSCoherus Biosciences Inc397.30%-113.31%
INVAInnoviva Inc119.90%-104.02%
ZVRAZevra Therapeutics Inc101.60%-103.40%
ABUSArbutus Biopharma Corp94.73%-103.17%
SAVACassava Sciences Inc.93.68%-103.14%
GLPGGalapagos NV86.83%-102.91%
CTNMContineum Therapeutics Inc - Class A83.13%-102.78%
BDTXBlack Diamond Therapeutics Inc80.77%-102.71%
NEUPNeuphoria Therapeutics Inc75.08%-102.52%
IPSCCentury Therapeutics Inc70.13%-102.35%
FULCFulcrum Therapeutics Inc69.26%-102.32%
CVACCureVac N.V.68.44%-102.29%
PRTAProthena Corporation plc64.05%-102.15%
HCWBHCW Biologics Inc63.16%-102.12%
QTTBQ32 Bio Inc61.90%-102.07%
AVIRAtea Pharmaceuticals Inc60.95%-102.04%
ASNDAscendis Pharma A/S57.30%-101.92%
PLXProtalix BioTherapeutics Inc54.27%-101.82%
AGENAgenus Inc52.20%-101.75%
CGENCompugen Ltd48.57%-101.63%
KRYSKrystal Biotech Inc48.07%-101.61%
RPRXRoyalty Pharma plc - Class A46.73%-101.57%
XOMAPXOMA Corp45.90%-101.54%
XOMAOXOMA Corp45.90%-101.54%
AUPHAurinia Pharmaceuticals Inc44.21%-101.48%
NXTCNextcure Inc43.49%-101.46%
CPRXCatalyst Pharmaceuticals Inc42.66%-101.43%
HALOHalozyme Therapeutics Inc39.83%-101.33%
ADMAAdma Biologics Inc39.59%-101.33%
XOMAXOMA Corp36.25%-101.21%
VRTXVertex Pharmaceuticals Inc34.53%-101.16%
EXELExelixis Inc34.46%-101.15%
SLNOSoleno Therapeutics Inc33.17%-101.11%
CRMDCorMedix Inc30.29%-101.01%
TNGXTango Therapeutics Inc29.52%-100.99%
ARGXArgen X SE28.20%-100.94%
CAICaris Life Sciences Inc - Class A27.98%-100.94%
JAZZJazz Pharmaceuticals plc27.42%-100.92%
SPROSpero Therapeutics Inc24.90%-100.83%
INCYIncyte Corp23.83%-100.80%
REGNRegeneron Pharmaceuticals Inc20.17%-100.68%
NAGENiagen Bioscience Inc20.07%-100.67%
ICCCImmucell Corp18.75%-100.63%
NERVMinerva Neurosciences Inc17.79%-100.60%
ALNYAlnylam Pharmaceuticals Inc16.99%-100.57%
ENVBEnveric Biosciences Inc16.64%-100.56%
TECHBio-Techne Corp16.39%-100.55%
HRMYHarmony Biosciences Holdings Inc15.08%-100.51%
ONCBeiGene Ltd15.02%-100.50%
RIGLRigel Pharmaceuticals14.71%-100.49%
BMRNBiomarin Pharmaceutical Inc13.77%-100.46%
VXRTVaxart Inc13.20%-100.44%
IMCRImmunocore Holdings plc12.16%-100.41%
VRNAVerona Pharma Plc11.56%-100.39%
SVASinovac Biotech Ltd11.25%-100.38%
FBIOFortress Biotech Inc10.80%-100.36%
TGTXTG Therapeutics Inc9.65%-100.32%
PHARPharming Group N.V.7.76%-100.26%
APLSApellis Pharmaceuticals Inc6.95%-100.23%
PTGXProtagonist Therapeutics Inc6.71%-100.22%
NUVBNuvation Bio Inc - Class A6.48%-100.22%
FBIOPFortress Biotech Inc6.40%-100.21%
GMABGenmab5.92%-100.20%
SRPTSarepta Therapeutics Inc2.98%-100.10%
BMEABiomea Fusion Inc2.37%-100.08%
ACADAcadia Pharmaceuticals Inc1.36%-100.05%
FENCFennec Pharmaceuticals Inc1.33%-100.04%
FOLDAmicus Therapeutics Inc0.91%-100.03%
HOTHHoth Therapeutics Inc0.17%-100.01%
BBLGBone Biologics Corp0.02%-100.00%